Loading insider details...
Beta
Latest Form 4 (Jun 8, 2026): Grant/Award of 23,931 AUPH shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 23,931 | n/a |
| May 16, 2025 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 63,724 | n/a |
| Apr 12, 2024 | abrdn Life Sciences Investors (HQL) | Purchase | 400 | $5.3K |
| Apr 12, 2024 | abrdn World Healthcare Fund (THW) | Purchase | 200 | $2.5K |
| Apr 12, 2024 | abrdn Healthcare Opportunities Fund (THQ) | Purchase | 600 | $11.7K |
| Apr 12, 2024 | abrdn Healthcare Investors (HQH) | Purchase | 525 | $8.6K |
| Mar 24, 2022 | TEKLA LIFE SCIENCES INVESTORS (HQL) | Purchase | 92 | $1.5K |
| Mar 24, 2022 | Tekla World Healthcare Fund (THW) | Purchase | 103 | $1.5K |
| Mar 24, 2022 | Tekla Healthcare Opportunities Fund (THQ) | Purchase | 69 | $1.5K |
| Mar 24, 2022 | TEKLA HEALTHCARE INVESTORS (HQH) | Purchase | 74 | $1.5K |